Zebra Capital Management LLC Natera, Inc. Transaction History

Zebra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$100.17 - $126.36 $570,668 - $719,872	-5,697 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$86.05 - $119.72 $53,092 - $73,867	-617 Reduced 9.77%	5,697 $647,000
Q1 2021 May 17, 2021	SELL	$91.47 - $124.36 $572,876 - $778,866	-6,263 Reduced 49.8%	6,314 $641,000
Q4 2020 Feb 16, 2021	BUY	$66.66 - $111.74 $77,792 - $130,400	1,167 Added 10.23%	12,577 $1.25 Million
Q3 2020 Nov 16, 2020	BUY	$45.89 - $72.67 $523,604 - $829,164	11,410 New	11,410 $824,000

504

120M

412K

270K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $12.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Zebra Capital Management LLC with notifications on news.